[DOI] [PubMed] [Google Scholar] 46.A phase II study on safety and efficacy of high-dose N-acetylcysteine in patients with cystic fibrosis
doi: 10.1007/s10787-022-00974-4 213 HuYZhangTChenJChengWChenJZhengZet al
Purity Greater than 98.2% as determined by analysis by RP-HPLC
Critically, these events were most prevalent during initiation/escalation of therapy and declined substantially over time
The benefits are well documented across many applications: faster tissue healing (3050% faster than natural healing), strong inflammation control without the side effects of traditional drugs, enhanced new blood vessel formation, less scar tissue (4050% less fibrosis), better functional recovery, healing across all tissue types (muscle, tendon, ligament, bone, organs), gut healing and protection, possible neuroprotective effects, cardiac protective properties, and an excellent safety profile with minimal side effects